BARCELONA, Spain – Anaconda Biomed S,L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding will be used for clinical studies of the company’s groundbreaking technology, regulatory submissions in international markets, further product development and manufacturing scale-up. “With this new round of funding, we will be
Innogest Capital is pleased to share the announcement of the sale of Beintoo to Publitalia '80, part of Mediaset Group. Beintoo is an exciting company and this transaction demonstrate our commitment to invest in and build innovative companies. This is particularly relevant news, given the current difficult environment. Below the press release issued on tuesday by Mediaset Group (in italian).
MILAN (ITALY), DECEMBER 4th 2019 – Hiroaki Tanaka and Hadi Abderrahim have been appointed partners by Innogest SGR’s Board of directors. They will join Claudio Giuliano and Giovanni Leo as senior team within Innogest’s healthcare practice, and strengthen specifically the oncology and precision medicine team, one of the signature verticals of the investment firm. Hiroaki Tanaka is an expert in
Former Microsoft Chief Operating Officer supports the international development of the SGR
MILAN, 25th SEPTEMBER 2019 – Newronika, a spin-off of world-class neurological research center Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together withexisting investors Innogest and Indaco Venture Partners SGR (“Indaco SGR”) on behalf of Indaco Ventures I and Atlante Ventures funds.
The round was led by Innogest Capital. The insurance services web platform has exceeded 200.000 registered users and aims to establish itself as an Italian leader in the sale of non-auto insurance
Italian scale up picks the biggest European VC backed funding for an on-demand e-grocery marketplace. Leading the round is FII Tech Growth, with participation from new investor Endeavor Catalyst, and current investors 360 Capital Partners and Innogest
Amadori, Cereal Docks and Gruppo Finiper, in collaboration with Deloitte and with the support of Innogest, Digital Magics, Seeds & Chips and Federalimentare Giovani are joining their forces to transform Milan to an international hub for food and retail innovation
Innogest participates in the round led by Sofinnova Partners. Funds will be used to accelerate the company’s international development and complete the registrational Phase III clinical trial of its lead product EryDex